2025.12.26
TCROSS Co., Ltd. is pleased to announce that it has been granted a Japanese patent for EarlyScripters, a proprietary algorithm integrated into its healthcare marketing analytics platform, InsighTCROSS .
The patented technology relates to an information processing method that quantitatively analyses physicians’ attributes and behavioural data to estimate the probability of being an Early Adopter—those physicians who play a pivotal role in early-stage product uptake. The invention was recognised for establishing a reproducible, data-driven framework that replaces conventional experience-based and qualitative physician targeting approaches. This enables pharmaceutical and medical device companies to identify influential physicians with high precision and to allocate sales and marketing resources more strategically during product launches.
When combined with InsighTCROSS ’s existing capabilities—such as sales activity optimisation, ROI analysis, and revenue structure visualisation—the patented EarlyScripters technology serves as a core engine supporting end-to-end decision-making. Specifically, it enables companies to determine which physicians to engage, what information to deliver, and in what sequence, based on quantitative evidence.
In addition, TCROSS plans to present this patented technology at HIMSS 2026, to be held in Las Vegas, USA, from March 9 to March 12, 2026. The presentation is scheduled on March 10 at 1:40 PM at the Business Operations Pavilion, where we will introduce the practical application and business impact of the EarlyScripters technology.
TCROSS Co., Ltd. will continue to enhance its data-driven marketing solutions by leveraging this patented technology, while actively pursuing partnerships with pharmaceutical and medical device companies both in Japan and internationally. We also plan to expand its global footprint by adapting InsighTCROSS and EarlyScripters to overseas markets.
InsighTCROSS is a decision-support model developed by TCROSS Co., Ltd. for pharmaceutical and medical device companies. By integrating statistical analysis and data science with traditional sales and marketing practices, InsighTCROSS enables the visualisation of physicians’ prescribing behaviours and decision-making criteria. This approach supports more effective strategy development, allowing companies to optimise resource allocation and reduce marketing costs. Ultimately, InsighTCROSS contributes to more appropriate healthcare spending and the advancement of a sustainable healthcare system.